Name: CGEN Income Statement - Compugen Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CGEN - Compugen Ltd.

USD | NASDAQ | Healthcare

CGEN Income Statement - Compugen Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	72.8	27.9	33.5	7.5	6.0	2.0	-	17.8	-	0.7	9.3	12.4	3.5	0.2	-	1.1	0.3
Cost of Revenue	9.3	7.9	2.0	1.0	0.7	0.1	-	1.0	-	0.2	1.6	3.3	2.5	0.2	-	0.2	-
Gross Profit	63.5	19.9	31.5	6.5	5.3	1.9	-	16.8	-	0.5	7.6	9.0	1.0	0.0	-	0.9	-
Operating Expenses
Research & Development	22.8	24.8	34.5	30.6	28.7	22.8	19.8	30.3	28.6	24.5	21.2	15.1	12.3	9.4	6.8
Operating Income
Operating Income	31.3	(14.9)	(13.0)	(35.4)	(35.1)	(31.5)	(28.9)	(23.2)	(37.4)	(32.6)	(20.9)	(12.3)	(17.0)	(13.5)
Non-Operating
Interest Income	3.9	3.5	3.0	1.4	0.9	1.8	0.9	0.6	0.5	0.7	0.8	0.3	0.2	0.3	0.4	-
Tax & Net
Income Tax Expense	0.1	4.5	9.0	0.1	0.0	0.0	(0.7)	-	-	0.0	0.4	0.4	0.5	-	-
Per Share
EPS Basic	0.38	(0.16)	(0.21)	(0.39)	(0.41)	(0.37)	(0.43)	(0.41)	(0.72)	(0.62)	(0.40)	(0.23)	(0.36)	(0.38)	(0.35)	-
Supplementary Data
EBITDA	31.8	(14.4)	(12.5)	(34.9)	(34.6)	(30.8)	(27.9)	(21.8)	(35.8)	(31.1)	(19.8)	(11.7)	(16.7)	(13.2)	(11.8)	(7.7)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)